Development and Ev Aluation of Lns Loded Topical Ointment of Amoroifine by QBD Approach

Authors

  • Meruva Bhagyaveni Department of Pharmaceutics, KGR Institute of Technology and Management, Rampally, Keesara(m), Medchal-Malkajgiri District, Hyderabad -501302, Telangana, India. Author
  • Dr. Anjaneyulu Professor and HOD, KGR Institute of Technology and Management, Rampally, Keesara(m), Medchal-Malkajgiri District, Hyderabad -501302, Telangana, India. Author
  • Vijay Kumar Gampa Principal and Professor, KGR Institute of Technology and Management, Rampally, Keesara(m), Medchal-Malkajgiri District, Hyderabad -501302, Telangana, India. Author

Keywords:

Tween 80, X-ray diffraction, Central Composite Design

Abstract

This research work investigates the dissolvability of tetrahydrocannabinol in different excipients and its formulation into lipid nanoparticles (LNs) for enhanced drug delivery. THC showed the highest solubility in olive oil, but solid lipid nanoparticles (SLNs) were formulated using Tween 80 as the surfactant for improved solubilization and stabilization. A pseudoternary phase diagram optimized excipient concentrations, ensuring stable formulations. DLS demonstrated optimalsize of particle& PDI for effective skin penetration, while zeta potential analysis indicated stability through steric and reduced electrostatic stabilization. High-resolution transmission electron microscopy (HRTEM) and nanoparticle tracking analysis (NTA) confirmed uniform, consistent particle sizes. Spectroscopic analyses (DSC,FTIR) &XRD validated the amorphous nature of THC within the formulations. Central Composite Design (CCD) optimization yielded a reliable model, showing strong potential for improving THC bioavailability in therapeutic applications.

Downloads

Published

2025-01-10

Issue

Section

Articles

How to Cite

Meruva, B., Dr., A., & Gampa, V. K. (2025). Development and Ev Aluation of Lns Loded Topical Ointment of Amoroifine by QBD Approach. Journal of Pharmaceutical and Biological Research, 13(1), 08-14. https://pharmaresearchlibrary.org/journals/index.php/jpbr/article/view/24